Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review

BACKGROUND AND PURPOSE: This work was undertaken to review the current cost-effectiveness analysis data on thrombolysis by intravenous (IV) therapy with recombinant tissue plasminogen activator (rtPA) for acute ischemic stroke. METHODS: PubMed was searched for articles published between 1995 and 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Kee-Taig, Shin, Dong Wook, Lee, Kyung-Jin, Oh, Myungju
Formato: Texto
Lenguaje:English
Publicado: Korean Neurological Association 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950916/
https://www.ncbi.nlm.nih.gov/pubmed/20944812
http://dx.doi.org/10.3988/jcn.2010.6.3.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950916/
https://www.ncbi.nlm.nih.gov/pubmed/20944812
http://dx.doi.org/10.3988/jcn.2010.6.3.117

Ejemplares similares